Production (Stage)
PharmaRoth Labs, Inc.
ROTH
$0.00
$0.000.00%
OTC PK
| 03/31/2011 | 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -- | -- | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -- | -- | -- | -- | -- |
|
|
|||||
| Total Current Assets | -- | -- | -- | -- | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -- | -- | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | 212.60% | 18.03% | -14.98% | -39.81% | 243.24% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,900.00% | 2,764.00% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 929.29% | 963.96% | 1,369.60% | -39.81% | 412.16% |
|
|
|||||
| Total Current Liabilities | 929.29% | 963.96% | 1,369.60% | -39.81% | 412.16% |
| Long-Term Debt | -- | -- | -- | 2,190.40% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 929.29% | 963.96% | 847.73% | 1,182.46% | 90.45% |
|
|
|||||
| Common Stock & APIC | 1,039.07% | 573.77% | 573.77% | 0.00% | 0.00% |
| Retained Earnings | -855.84% | -725.03% | -669.08% | -453.87% | -31.86% |
| Treasury Stock & Other | -- | -- | -- | 0.00% | -- |
| Total Common Equity | -679.16% | -875.07% | -768.18% | -1,182.46% | -90.45% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -679.16% | -875.07% | -768.18% | -1,182.46% | -90.45% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -679.16% | -875.07% | -768.18% | -1,182.46% | -90.45% |
|
|
|||||